A bill (HB 12) recently approved by the Utah Legislature that would permit criminal charges against women who seek an illegal abortion “may have opened a loophole” allowing women to be charged with murder if they experience a miscarriage because of “reckless behavior,” ABC News reports…
No Comments »
Filed under: Women's Health
Despite gains in women’s rights in the 15 years since the Beijing Declaration, U.N. Female Deputy Secretary-General Asha-Rose Migiro on Monday during the opening of the U.N. Commission on the Status of Women (CSW) meeting acknowledged more action is needed to help countries advance gender equality and women’s empowerment, VOA News reports…
No Comments »
Filed under: Women's Health
Free Economies Essential For Disaster Preparedness The earthquake in Chile “was the fifth biggest ever measured, and several hundred times larger than the one that killed more than 220,000 in Haiti,” according to a Wall Street Journal editorial. The editorial highlights Chile’s preparation for earthquakes, including stricter building codes…
No Comments »
Filed under: Women's Health
Like any successful team effort, the best qualities of two drugs commonly prescribed for enlarged prostate yielded better results than either of the medicines alone, according to a new study from UT Southwestern Medical Center…
No Comments »
Filed under: Men's Health
WASHINGTON (MedPage Today) — Americans are growing more health-conscious while reading food labels and selecting foods to eat, a recently published FDA survey on health and diet found.
No Comments »
Filed under: General Health News
WASHINGINTON (MedPage Today) — The FDA approved the first generic version of the benign prostatic hyperplasia (BPH) medication tamsulosin (Flomax).
No Comments »
Filed under: Pharmacy News
The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy - the most common form of epilepsy in kids - has established an evidence-based approach for initial drug therapy.
No Comments »
Filed under: Pharmacy News
Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI’s OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the [...]
No Comments »
Filed under: Pharmacy News
The experimental drug belatacept can prevent graft rejection in kidney transplant recipients while better preserving kidney function when compared with standard immunosuppressive drugs, data from two international phase III clinical trials show.
No Comments »
Filed under: Pharmacy News
Anavex Life Sciences Corp. today issued a statement following today’s announcement from Pfizer and Medivation (MDVN) that their investigational Alzheimer’s drug Dimebon did not meet either its co-primary or secondary endpoints compared to placebo during pivotal Phase 3 clinical trials.
No Comments »
Filed under: Pharmacy News
